Evidence map›Paper›PMID 27980999›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2016

Anti-Metastatic and Anti-Angiogenic Activities of Core-Shell SiO

Yanjing Zhu, Rongrong Zhu, Mei Wang, Bin Wu, Xiaolie He, Yechang Qian, Shilong Wang

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Stable Cu Catalysts Supported by Two-dimensional SiOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  4. The emergence of nanoporous materials in lung cancer therapy.Science and technology of advanced materials · 2022
    Review
  5. Article
  6. Article
  7. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Anti-Metastatic and Anti-Angiogenic Activities of Core-Shell SiOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yanjing ZhuResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Rongrong ZhuResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Mei WangResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Bin WuResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Xiaolie HeResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Yechang QianDepartment of Respiratory Disease Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine Shanghai 201900 China.
Shilong WangResearch Center for Translational Medicine at East Hospital School of Life Science and Technology Tongji University Shanghai 200092 China.
Shanghai East Hospital · CNIntegrated Chinese Medicine (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, nanoparticles have gained a great attention in the anti-tumor research area. However, to date, studies on the anti-metastasis action of core-shell SiO

Indexed as

anti‐angiogenicanti‐metastasisetoposidelung cancerSiO2@LDH

Identifiers

PMID27980999
PMCPMC5102674
OpenAlexW2530177055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.